Recordati Rare Diseases North America
Jeremy Le Brun has extensive experience in the pharmaceutical industry, currently serving as a Key Account Manager at Recordati Rare Diseases Inc. since January 2020. Previously, Jeremy held positions including International Brand Manager and Key Account Manager at Sobi from 2011 to 2020, where significant sales growth was achieved for various products. Prior roles include Divisional Sales Executive at Napp, where Jeremy focused on secondary care, formulary approval, and team training. Notable accomplishments include driving substantial sales increases for Butrans, Oxycontin, and Oxynorm. Jeremy's educational background includes a BA (Hons) in Business Studies from Staffordshire University, complemented by A Levels from Wellington School.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.